Record overview
Status and phase
Status: RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Daiichi Sankyo
Condition: Hematological Malignancies, B-cell Non-Hodgkin Lymphoma
NCT07220616
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.